Comparative betaherpes viral genome and virion structure

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 177-203

  Davison, Andrew J ^a   Bhella, David ^a  

^a INSTITUTE OF VIROLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929279780     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.015     Document Type: Chapter

References (322)

1. Adair, R., Douglas, E. R., Maclean, J. B. et al. (2002). The products of human cytomegalovirus genes UL23, UL24, UL43 and US22 are tegument components. J. Gen. Virol., 83, 1315-1324.
2. Adamo, J. E., Schroer, J., and Shenk, T. (2004). Human cytomegalovirus TRS1 protein is required for efficient assem-bly of DNA-containing capsids. J. Virol., 78, 10221-10229.
3. Adler, B., Scrivano, L., Ruzcics, Z., Rupp, B., Sinzger, C., and Koszi-nowski, U. (2006). Role of human cytomegalovirus UL131A in cell type-specific virus entry and release. J. Gen. Virol., 87, 2451-2460.
4. Agulnick, A. D., Thompson, J. R., Iyengar, S., Pearson, G., Ablashi, D., and Ricciardi, R. P. (1993). Identification of a DNA-binding protein of human herpesvirus 6, a putative DNA polymerase stimulatory factor. J. Gen. Virol., 74, 1003-1009.
5. Ahn, J. H. and Hayward, G. S. (2000). Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology, 274, 39-55.
6. Ahn, K., Angulo, A., Ghazal, P., Peterson, P. A., Yang, Y., and Fruh, K. (1996). Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl Acad. Sci. USA, 93, 10990-10995.
7. Ahn, K., Gruhler, A., Galocha, B. et al. (1997). The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity6, 613-621.
8. Ahn, J. H., Jang, W. J., and Hayward, G. S. (1999). The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10). J. Virol., 73, 10458-10471.
9. Akter, P., Cunningham, C., McSharry, B. P. et al. (2003). Two novel spliced genes in human cytomegalovirus. J. Gen. Virol., 84, 1117-1122.
10. Al-Barazi, H. O. and Colberg-Poley, A. M. (1996). The human cytomegalovirus UL37 immediate-early regulatory protein is an integral membrane N-glycoprotein which traffics through the endoplasmic reticulum and Golgi apparatus. J. Virol., 70, 7198-7208.
11. Allal, C., Buisson-Brenac, C., Marion, V. et al. (2004). Human cytomegalovirus carries a cell-derived phospholipase A2 required for infectivity. J. Virol., 78, 7717-7726.
12. Anders, D. G. and Gibson, W. (1988). Location, transcript analy-sis, and partial nucleotide sequence of the cytomegalovirus gene encoding an early DNA-binding protein with similari-ties to ICP8 of herpes simplex virus type 1. J. Virol., 62,1364-1372.
13. Ansari, A. and Emery, V. C. (1999). The U69 gene of human her-pesvirus 6 encodes a protein kinase which can confer ganci-clovir sensitivity to baculoviruses. J. Virol., 73, 3284-3291.
14. Appleton, B. A., Loregian, A., Filman, D. J., Coen, D. M., and Hogle, J. M. (2004). The cytomegalovirus DNA polymerase subunit UL44 forms aC clamp-shaped dimer. Mol. Cell., 15, 233-244.
15. Arav-Boger, R., Willoughby, R. E., Pass, R. F. et al. (2002). Polymor-phisms of the cytomegalovirus (CMV)-encoded tumor necro-sisfactor-a. and [3-chemokine receptors in congenital CMVdis-ease. J. Infect. Dis., 186, 1057-1064.
16. Arlt, H., Lang, D., Gebert, S., and Stamminger, T. (1994). Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter. J. Virol., 68, 4117-4125.
17. Atalay, R., Zimmermann, A., Wagner, M. et al.(2002). Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcy receptor homologs. J. Virol., 76, 8596-8608.
18. Bahr, U. and Darai, G. (2001). Analysis and characterization of the complete genome of tupaia (tree shrew) herpesvirus. J. Virol., 75, 4854-4870.
19. Baldick, C. J. Jr. and Shenk, T. (1996). Proteins associated with purified human cytomegalovirus particles. J. Virol., 70, 6097-6105.
20. Baxter, M. K. and Gibson, W. (2001). Cytomegalovirus basic phos-phoprotein (pUL32) binds to capsids in vitro through its amino one-third. J. Virol., 75, 6865-6873.
21. Bechtel, J. T. and Shenk, T. (2002). Human cytomegalovirus UL47 tegument protein functions after entry and before immediate-early gene expression. J. Virol., 76, 1043-1050.
22. Benedict, C. A., Butrovich, K. D., Lurain, N. S. et al. (1999). Cut-ting edge: A novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J. Immunol., 162, 6967-6970.
23. Benko, D. M., Haltiwanger, R. S., Hart, G. W., and Gibson, W. (1988). Virion basic phosphoprotein from human cytomegalovirus contains O-linked N-acetylglucosamine. Proc. Natl Acad. Sci. USA, 85, 2573-2577.
24. Bhella, D., Rixon, F. J., and Dargan, D. J. (2000). Cryomicroscopy of human cytomegalovirus virions reveals more densely packed genomic DNA than in herpes simplex virus type 1. J. Mol. Biol., 295, 155-161.
25. Biron, K. K., Harvey, R. J., Chamberlain, S. C. et al. (2002). Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob. Agents Chemother., 46, 2365-2372.
26. Blewett, E. L., White, G., Saliki, J. T., and Eberle, R. (2001). Isola-tion and characterization of an endogenous cytomegalovirus (BaCMV) from baboons. Arch. Virol., 146, 1723-1738.
27. Blewett, E. L., Lewis, J., Gadsby, E. L., Neubauer, S. R., and Eberle, R. (2003). Isolation of cytomegalovirus and foamy virus from the drill monkey (Mandrillus leucophaeus) and prevalence of antibodies to these viruses amongst wild-born and captive-bred individuals. Arch. Virol., 148, 423-433.
28. Boehme, K. W., Singh, J., Perry, S. T., and Compton, T. (2004). Human cytomegalovirus elicits a coordinated cellular antivi-ral response via envelope glycoprotein B. J. Virol., 78, 1202-1211.
29. Bogner, E,. Reschke, M., Reis, B., Mockenhaupt, T., and Radsak, K. (1993). Identification of the gene product encoded by ORF UL56 of the human cytomegalovirus genome. Virology, 196, 290-293.
30. Bogner, E., Radsak, K., and Stinski, M. F. (1998). The gene product of human cytomegalovirus open reading frame UL56 binds the pac motif and has specific nuclease activity. J. Virol., 72, 2259-2264.
31. Booy, F. P., Newcomb, W. W., Trus, B. L., Brown, J. C., Baker, T. S., and Steven, A. C. (1991). Liquid-crystalline, phage-like packing of encapsidated DNA in herpes simplex virus. Cell, 64, 1007-1015.
32. Booy, F. P., Trus, B. L., Newcomb, W. W., Brown, J. C., Conway, J. F., and Steven, A. C. (1994). Finding a needle in a haystack: Detection of a small protein (the 12-kDa VP26) in a large complex (the 200-MDa capsid of herpes simplex virus). Proc. Natl Acad. Sci. USA, 91, 5652-5656.
33. Borst, E. M., Hahn, G., Koszinowski, U. H., and Messerle, M. (1999). Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: A new approach for construction of HCMV mutants. J. Virol., 73, 8320-8329.
34. Boyle, K. A. and Compton, T. (1998). Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B. J. Virol., 72, 1826-1833.
35. Bradshaw, P. A., Duran-Guarino, M. R., Perkins, S. et al. (1994). Localization of antigenic sites on human cytomegalovirus virion structural proteins encoded by UL48 and UL56. Virol-ogy, 205, 321-328.
36. Bresnahan, W. A. and Shenk, T. (2000a). A subset of viral transcripts packaged within human cytomegalovirus particles. Science, 288, 2373-2376.
37. Bresnahan, W. A. and Shenk, T. E. (2000b). UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc. Natl Acad. Sci. USA, 97, 14506-14511.
38. Browne, E. P. and Shenk, T. (2003). Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc. Natl Acad. Sci. USA, 100, 11439-11444.
39. Browne, E. P., Wing, B., Coleman, D. and Shenk, T. (2001). Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: Viral block to the accumulation of antiviral mRNAs. J. Virol., 75, 12319-12330.
40. Browne, H., Smith, G., Beck, S., and Minson, T. (1990). A com-plex between the MHC class I homologue encoded by human cytomegalovirus and [3-2 microglobulin. Nature, 347, 770-772.
41. Buerger, I., Reefschlaeger, J., Bender, W. et al. (2001). A novel non-nucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. J. Virol., 75, 9077-9086.
42. Butcher, S. J., Aitken, J., Mitchell, J., Gowen, B., and Dargan, D. J. (1998). Structure of the human cytomegalovirus B capsid by electron cryomicroscopy and image reconstruction. J. Struct. Biol., 124, 70-76.
43. Caposio, P., Riera, L., Hahn, G., Landolfo, S., and Gribaudo, G.(2004). Evidence that the human cytomegalovirus 46-kDa UL72 pro-tein is not an active dUTPase but a late protein dispensable for replication in fibroblasts. Virology, 325, 264-276.
44. Cha, T. A., Tom, E., Kemble, G. W., Duke, G. M., Mocarski, E. S., and Spaete, R. R. (1996). Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol., 70, 78-83.
45. Chan, P. K., Li, C. K., Chik, K. W. et al. (2003). Genetic variation of glycoproteins B and H of human herpesvirus 7 in Hong Kong. J. Med. Virol., 71, 429-433.
46. Chang, C. P., Vesole, D. H., Nelson, J., Oldstone, M. B., and Stin-ski, M. F. (1989). Identification and expression of a human cytomegalovirus early glycoprotein. J. Virol., 63, 3330-3337.
47. Chang, W. L. and Barry, P. A. (2003). Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogen-esis. J. Virol., 77, 5073-5083.
48. Chang, Y. N., Jeang, K. T., Lietman, T., and Hayward, G. S. (1995). Structural organization of the spliced immediate-early gene complex that encodes the major acidic nuclear (IE1) and transactivator (IE2) proteins of African green monkey cytomegalovirus. J. Biomed. Sci., 2, 105-130.
49. Chee, M., Rudolph, S. A., Plachter, B., Barrell, B., and Jahn, G. (1989). Identification of the major capsid protein gene of human cytomegalovirus. J. Virol., 63, 1345-1353.
50. Chee, M. S., Bankier, A. T., Beck, S. et al. (1990). Analysis of the pro-teincodingcontentofthesequenceofhumancytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol., 154, 125-169.
51. Chen, D. H., Jiang, H., Lee, M., Liu, F., and Zhou, Z. H. (1999). Three-dimensional visualization of tegument/capsid interactions in the intact human cytomegalovirus. Virology, 260, 10-16.
52. Chen, P., Tsuge, H., Almassy, R.J. et al.(1996). Structureofthehuman cytomegalovirus protease catalytic domain reveals a novel ser-ine protease fold and catalytic triad. Cell, 86, 835-843.
53. Child, S. J., Hakki, M., De Niro, K. L., and Geballe, A. P. (2004). Evasion of cellular antiviral responses by human cytomegalovirusTRS1 and IRS1. J. Virol., 78, 197-205.
54. Chou, S., Marousek, G. I., Senters, A. E., Davis, M. G., and Biron, KK. (2004). Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir. J. Virol., 78, 7124-7130.
55. Cosman, D., Fanger, N., Borges, L. et al. (1997). A novel immu-noglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity, 7, 273-282.
56. Cosman, D., Mullberg, J., Sutherland, C. L. et al. (2001). ULBPs, novel MHC class I-related molecules, bind to CMV glycopro-tein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity, 14, 123-133.
57. Courcelle, C. T., Courcelle, J., Prichard, M. N., and Mocarski, E. S. (2001). Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication. J. Virol., 75, 7592-7601.
58. Cranage, M. P., Kouzarides, T., Bankier, A. T. et al. (1986). Identi-fication of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J., 5, 3057-3063.
59. Cranage, M. P., Smith, G. L., Bell, S. E. et al. (1988). Identifica-tion and expression of a human cytomegalovirus glycopro-tein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H. J. Virol., 62, 1416-1422.
60. Dal Monte, P., Pignatelli, S., Zini, N. et al. (2002). Analysis of intracel-lular and intraviral localization of the human cytomegalovirus UL53 protein. J. Gen. Virol., 83, 1005-1012.
61. D'Aquila, R. T., Hayward, G. S., and Summers, W. C. (1989). Physi-cal mapping of the human cytomegalovirus (HCMV) (Towne) DNA polymerase gene: DNA-mediated transfer of a genetic marker for an HCMV gene. Virology, 171, 312-316.
62. Dargan, D. J., Jamieson, F. E., MacLean, J., Dolan, A., Addison, C., and McGeoch, D. J. (1997). The published DNA sequence of human cytomegalovirus strain AD169 lacks 929 base pairs affecting genes UL42 and UL43. J. Virol., 71, 9833-9836.
63. Davison, A. J. and Stow, N. D. (2005). New genes from old: Rede-ployment of dUTPase by herpesviruses. J. Virol., 79, 12880-12892.
64. Davison, A. J., Dolan, A., Akter, P. et al. (2003a). The human cytomegalovirusgenome revisited: Comparisonwith the chim-panzee cytomegalovirus genome. J. Gen. Virol., 84, 17-28.
65. Davison, A. J., Akter, P., Cunningham, C. et al. (2003b). Homol-ogy between the human cytomegalovirus RL11 gene fam-ily and human adenovirus E3 genes. J. Gen. Virol., 84, 657-663.
66. Dhepakson, P., Mori, Y., Jiang, Y. B. et al.(2002). Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity. J. Gen. Virol., 83, 847-854.
67. Dittmer, A. and Bogner, E. (2005). Analysis of the quaternary struc-ture of the putative HCMV portal protein pUL104. Biochem-istry, 44, 759-765.
68. Dolan, A., Cunningham, C., Hector, R. D. et al. (2004). Genetic con-tent of wild type human cytomegalovirus. J. Gen. Virol., 85, 1301-1312.
69. Dominguez, G., Black, J. B., Stamey, F. R., Inoue, N., and Pellett, P. E. (1996). Physical and genetic maps of the human herpesvirus 7 strain SB genome. Arch. Virol., 141, 2387-2408.
70. Dominguez, G., Dambaugh, T. R., Stamey, F. R., Dewhurst, S., Inoue, N., and Pellett, P. E. (1999). Human herpesvirus 6B genome sequence: Coding content and comparison with human her-pesvirus 6A. J. Virol., 73, 8040-8052.
71. Dunn, C., Chalupny, N. J., Sutherland, C. L. et al. (2003a). Human cytomegalovirus glycoprotein UL16 causes intracellu-lar sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J. Exp. Med., 197, 1427-1439.
72. Dunn, W., Chou, C., Li, H. et al. (2003b). Functional profiling of a human cytomegalovirus genome. Proc. Natl Acad. Sci. USA, 100, 14223-14228.
73. Ebeling, A., Keil, G. M., Knust, E. and Koszinowski, U. H. (1983a). Molecular cloning and physical mapping of murine cytomegalovirus DNA. J. Virol., 47, 421-433.
74. Ebeling, A., Keil, G., Nowak, B., Fleckenstein, B., Berthelot, N., and Sheldrick, P. (1983b). Genome structure and virion polypep-tides of the primate herpesviruses Herpesvirus aotustypes 1 and 3: Comparison with human cytomegalovirus. J. Virol., 45, 715-726.
75. Ehlers, B. and Lowden, S. (2004). Novel herpesviruses of Suidae: Indicators for a second genogroup of artiodactyl gammaher-pesviruses. J. Gen. Virol., 85, 857-862.
76. Ehlers, B., Ulrich, S., and Goltz, M. (1999). Detection of two novel porcine herpesviruses with high similarity to gamma-herpesviruses. J. Gen. Virol., 80, 971-978.
77. Ehlers, B., Burkhardt, S., Goltz, M. et al. (2001). Genetic and ultra-structural characterization of a European isolate of the fatal endotheliotropic elephant herpesvirus. J. Gen. Virol., 82, 475-482.
78. Eickmann, M., Lange, R., Ohlin, M., Reschke, M., and Radsak, K. (1998). Effect of cysteine substitutions on dimerization and interfragmentlinkage of human cytomegalovirus glycoprotein B (gp UL55). Arch. Virol., 143, 1865-1880.
79. Ellinger, K., Neipel, F., Foa-Tomasi, L., Campadelli-Fiume, G., and Fleckenstein, B. (1993). The glycoprotein B homologue of human herpesvirus 6. J. Gen. Virol., 74, 495-500.
80. Ertl, P. F. and Powell, K. L.(1992). Physical and functional interaction of human cytomegalovirus DNA polymerase and its accessory protein (ICP36) expressed in insect cells. J. Virol., 66, 4126-4133.
81. Fraile-Ramos, A., Pelchen-Matthews, A., Kledal, T. N., Browne, H., Schwartz, T. W., and Marsh, M. (2002). Localization of HCMV UL33 and US27 in endocytic compartments and viral mem-branes. Traffic, 3, 218-232.
82. French, C., Menegazzi, P., Nicholson, L., Macaulay, H., DiLuca, D., and Gompels U. A. (1999). Novel, nonconsensus cellular splic-ing regulates expression of a gene encoding a chemokine-like protein that shows high variation and is specific for human herpesvirus 6 Virology, 262, 139-151.
83. Furman, M. H., Dey, N., Tortorella, D., and Ploegh, H. L. (2002). The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules. J. Virol., 76, 11753-11756.
84. Gao, M. and Isom, H. C. (1984). Characterization of the guinea pig cytomegalovirus genome by molecular cloning and physical mapping. J. Virol., 52, 436-447.
85. Gao, J. L. and Murphy, P. M. (1994). Human cytomegalovirus open reading frame US28 encodes a functional [3 chemokine recep-tor. J. Biol. Chem., 269, 28539-28542.
86. Gao, M., Robertson, B. J., McCann, P. J. et al. (1998). Func-tional conservations of the alkaline nuclease of herpes sim-plex type 1 and human cytomegalovirus. Virology, 249, 460-470.
87. Gawn, J. M. and Greaves, R. F. (2002). Absence of IE1 p72 pro-tein function during low-multiplicity infection by human cytomegalovirus results ina broad block to viral delayed-early gene expression. J. Virol., 76, 4441-4455.
88. Gebert, S., Schmolke, S., Sorg, G., Floss, S., Plachter, B., and Stam-minger, T. (1997). The UL84 protein of human cytomegalovirus acts as a transdominant inhibitor of immediate-early-mediated transactivation that is able to prevent viral replica-tion. J. Virol., 71, 7048-7060.
89. Gewurz, B. E., Gaudet, R., Tortorella, D., Wang, E. W., Ploegh, H. L., and Wiley, D. C. (2001). Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. Proc. Natl Acad. Sci. USA, 98, 6794-6799.
90. Gewurz, B. E., Ploegh, H. L., and Tortorella, D. (2002). US2, a human cytomegalovirus-encoded typeI membrane protein, contains a non-cleavable amino-terminal signal peptide. J. Biol. Chem., 277, 11306-11313.
91. Gibson, W. (1983). Protein counterparts of human and simian cytomegaloviruses. Virology, 128, 391-406.
92. Gibson, W. (1996). Structure and assembly of the virion. Intervirol-ogy39, 389-400.
93. Gibson, W., van Breemen, R., Fields, A., LaFemina, R., and Irmiere, A. (1984). D, L-a-difiuoromethylornithine inhibits human cytomegalovirus replication. J. Virol., 50, 145-154.
94. Gibson, W., Baxter, M. K., and Clopper, K. S. (1996a). Cytomegalovirus “missing” capsid protein identified as heat-aggregable product of human cytomegalovirus UL46. J. Virol., 70, 7454-7461.
95. Gibson, W., Clopper, K. S., Britt, W. J. and Baxter, M. K. (1996b). Human cytomegalovirus (HCMV) smallest capsid protein identified as product of short open reading frame located between HCMV UL48 and UL49. J. Virol., 70, 5680-5683.
96. Goldmacher, V. S., Bartle, L. M., Skaletskaya, A. et al. (1999). A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl Acad. Sci. USA, 96, 12536-12541.
97. Gompels, U. A., Nicholas, J., Lawrence, G. et al. (1995). The DNA sequence of human herpesvirus-6: Structure, coding content, and genome evolution. Virology, 209, 29-51.
98. Gravel, A., Gosselin, J., and Flamand, L. (2002). Human herpesvirus 6 immediate-early 1 protein is a sumoylated nuclear phos-phoprotein colocalizing with promyelocyticleukemia protein-associated nuclear bodies. J. Biol. Chem., 277, 19679-19687.
99. Gravel, A., Tomoiu, A., Cloutier, N., Gosselin, J., and Flamand, L. (2003). Characterization of the immediate-early 2 protein of human herpesvirus 6, a promiscuous transcriptional activator. Virology, 308, 340-353.
100. Greaves, R. F. and Mocarski, E. S. (1998). Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1mutant. J. Virol., 72, 366-379.
101. Greijer, A. E., Dekkers, C. A., and Middeldorp, J. M. (2000). Human cytomegalovirus virions differentially incorporate viral and host cell RNA during the assembly process. J. Virol., 74, 9078-9082.
102. Gretch, D. R., Kari, B., Rasmussen, L., Gehrz, R. C., and Stinski, M. F. (1988). Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirus. J. Virol., 62, 875-881.
103. Guo, Y. W. and Huang, E. S. (1993). Characterization of a struc-turally tricistronic gene of human cytomegalovirus composed of US 18, US 19, and US 20. J. Virol., 67, 2043-2054.
104. Hagemeier, C., Walker, S., Caswell, R., Kouzarides, T., and Sinclair, J. (1992). The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates het-erologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. J. Virol., 66, 4452-4456.
105. Hahn, G., Revello, M. G., Patrone, M. et al. (2004). Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J. Virol., 78, 10023-10033
106. Hansen, S. G., Strelow, L. I., Franchi, D. C., Anders, D. G., and Wong, S. W. (2003). Complete sequence and genomic analysis of rhe-sus cytomegalovirus. J. Virol., 77, 6620-6636.
107. Hayashi, M. L., Blankenship, C., and Shenk, T. (2000). Human cytomegalovirus UL69 protein is required for efficient accu-mulation of infected cells in the G1 phase of the cell cycle. Proc. Natl Acad. Sci. USA, 97, 2692-2696.
108. He, Y. S., Xu, L. and Huang, E. S. (1992). Characterization of human cytomegalovirusUL84early gene and identification of its puta-tive protein product. J. Virol., 66, 1098-1108.
109. Hegde, N. R., Tomazin, R. A., Wisner, T. W. et al. (2002). Inhibi-tion of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: A novel mechanism for evading major histocompatibility complex class II antigen pre-sentation. J. Virol., 76, 10929-10941.
110. Heider, J. A., Bresnahan, W. A., and Shenk, T. E. (2002). Construc-tion of a rationally designed human cytomegalovirus variant encoding a temperature-sensitive immediate-early 2 protein. Proc. Natl Acad. Sci. USA, 99, 3141-3146.
111. Heilbronn, R., Jahn, G., Burkle, A., Freese, U. K., Fleckenstein, B., and zur Hausen, H. (1987). Genomic localization, sequence analy-sis, and transcription of the putative human cytomegalovirus DNA polymerase gene. J. Virol., 61, 119-124.
112. Hermiston, T. W., Malone, C. L., Witte, P. R., and Stinski, M. F. (1987). Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimu-lates gene expression from an inducible promoter. J. Virol., 61, 3214-3221.
113. Hewitt, E. W., Gupta, S. S., and Lehner, P. J. (2001). The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J., 20, 387-396.
114. Hijikata, M., Takahashi, K., and Mishiro, S.(1999). Completecircular DNA genome of a TT virus variant (isolate name SANBAN) and 44 partial ORF2 sequences implicating a great degree of diversity beyond genotypes. Virology, 260, 17-22.
115. Hitomi, S., Kozuka-Hata, H., Chen, Z., Sugano, S., Yamaguchi, N., and Watanabe, S. (1997). Human cytomegalovirus open reading frame UL11 encodes a highly polymorphic protein expressed on the infected cell surface. Arch. Virol., 142, 1407-1427.
116. Hofmann, H., Sindre, H., and Stamminger, T. (2002). Func-tional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx. J. Virol., 76, 5769-5783.
117. Homer, E. G., Rinaldi, A., Nicholl, M. J., and Preston, C. M. (1999). Activation of herpesvirus gene expression by the human cytomegalovirus protein pp71. J. Virol., 73, 8512-8518.
118. Huang, E. S., Kilpatrick, B., Lakeman, A., and Alford C. A. (1978). Genetic analysis of a cytomegalovirus-like agent isolated from human brain. J. Virol., 26, 718-723.
119. Huber, M. T. and Compton, T. (1997). Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex. J. Virol., 71, 5391-5398.
120. Huber, M. T. and Compton, T. (1998). The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex. J. Virol., 72, 8191-8197.
121. Huber, M. T., Tomazin, R., Wisner, T., Boname, J., and Johnson, D. C. (2002). Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. J. Virol., 76, 5748-5758.
122. Inoue, N., and Pellett, P. E. (1995). Human herpesvirus 6B origin-binding protein: DNA-binding domain and consensus binding sequence. J. Virol., 69, 4619-4627.
123. Inoue, N., Dambaugh, T. R., Rapp, J. C., and Pellett, P. E. (1994). Alphaherpesvirusorigin-binding protein homolog encoded by human herpesvirus 6B, a betaherpesvirus, binds to nucleotide sequences that aresimilar to oriregionsof alphaherpesviruses. J. Virol., 68, 4126-4136.
124. Irmiere, A. and Gibson, W. (1983). Isolation and characterization of a noninfectious virion-like particle released from cells infected withhumanstrainsofcytomegalovirus. Virology, 130,118-133.
125. Irmiere, A. and Gibson, W. (1985). Isolation of human cytomegalovirus intranuclear capsids, characterization of their protein constituents, and demonstration that the B-capsid assembly protein is also abundant in noninfectious enveloped particles. J. Virol., 56, 277-283.
126. Isegawa, Y., Ping, Z., Nakano, K., Sugimoto, N., and Yamanishi, K. (1998). Human herpesvirus 6 open reading frame U12 encodes a functional [3-chemokine receptor. J. Virol., 72, 6104-6112.
127. Isegawa, Y., Mukai, T., Nakano, K. et al. (1999). Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J. Virol., 73, 8053-8063.
128. Ishov, A. M., Vladimirova, O. V., and Maul, G. G. (2002). Daxx-mediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains. J. Virol., 76, 7705-7712.
129. Jahn, G., Kouzarides, T., Mach, M. et al. (1987). Map position and nucleotide sequence of the gene for the large structural phos-phoprotein of human cytomegalovirus. J. Virol., 61,1358-1367.
130. Jeang, K. T. and Hayward, G. S. (1983). A cytomegalovirus DNA sequence containing tracts of tandemly repeated CA dinu-cleotides hybridizes to highly repetitive dispersed elements in mammalian cell genomes. Mol. Cell. Biol., 3, 1389-1402.
131. Jones, B. C., Logsdon, N. J., Josephson, K., Cook, J., Barry, P. A., and Walter, M. R. (2002). Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc. Natl Acad. Sci. USA, 99, 9404-9409.
132. Jones, T. R. and Sun, L. (1997). Human cytomegalovirus US2 desta-bilizes major histocompatibility complex class I heavy chains. J. Virol., 71, 2970-2979.
133. Jones, T. R., Hanson, L. K., Sun, L., Slater, J. S., Stenberg, R. M., and Campbell, A. E. (1995). Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol., 69, 4830-4841.
134. Jones, T. R., Wiertz, E. J., Sun, L., Fish, K. N., Nelson, J. A., and Ploegh, H. L. (1996). Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl Acad. Sci. USA, 93, 11327-11333.
135. Kalejta, R. F. and Shenk, T. (2003). Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc. Natl Acad. Sci. USA, 100, 3263-3268.
136. Kari, B., Goertz, R., and Gehrz, R. (1990). Characterization of cytomegalovirus glycoproteins in a family of complexes desig-nated gC-II with murine monoclonal antibodies. Arch. Virol., 112, 55-65.
137. Kari, B., Li, W., Cooper, J., Goertz, R., and Radeke, B. (1994). The human cytomegalovirus UL100 gene encodes the gC-II glyco-proteins recognized by group 2 monoclonal antibodies. J. Gen. Virol., 75, 3081-3086.
138. Kashanchi, F., Araujo, J., Doniger, J. (1997). Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant trans-forming activity and its protein binds to p53. Oncogene, 14, 359-367.
139. Kaye, J., Browne, H., Stoffel, M., and Minson, T. (1992a). The UL16 gene of human cytomegalovirus encodes a glycoprotein that is dispensable for growth in vitro. J. Virol., 66, 6609-6615.
140. Kaye, J. F., Gompels, U. A., and Minson, A. C. (1992b). Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. J. Gen. Virol., 73, 2693-2698.
141. Kemble, G. W., McCormick, A. L., Pereira, L., and Mocarski, E. S. (1987). A cytomegalovirus protein with properties of herpes simplex virus ICP8: Partial purification of the polypeptide and map position of the gene. J. Virol., 61, 3143-3151.
142. Kenzelmann, M. and Muhlemann, K. (2000). Transcriptome analysis of Fibroblast cells immediate-early after human cytomegalovirus infection. J. Mol. Biol., 304, 741-751.
143. Koch, H. G., Delius, H., Matz, B., Flugel, R. M., Clarke, J., and Darai, G. (1985). Molecular cloning and physical mapping of the tupaia herpesvirus genome. J. Virol., 55, 86-95.
144. Komazin, G., Ptak, R. G., Emmer, B. T., Townsend, L. B., and Drach, J. C. (2003). Resistance of human cytomegalovirus to the benz-imidazole L-ribonucleoside maribavir maps to UL27. J. Virol., 77, 11499-11506.
145. Komazin, G., Townsend, L. B., and Drach, J. C. (2004). Role of a mutation in human cytomegalovirus gene UL104 in resistance to benzimidazole ribonucleosides. J. Virol., 78, 710-715.
146. Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V., and Pestka, S. (2000). Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl Acad. Sci. USA, 97, 1695-1700.
147. Kouzarides, T., Bankier, A. T., Satchwell, S. C., Weston, K., Tomlin-son, P., and Barrell, B. G. (1987). Sequence and transcription analysis of the human cytomegalovirus DNA polymerase gene. J. Virol., 61, 125-133.
148. Krosky, P. M., Underwood, M. R., Turk, S. R. et al. (1998). Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. J. Virol., 72, 4721-4728.
149. Krosky, P. M., Baek, M. C., and Coen, D. M. (2003a). The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J. Virol., 77, 905-914.
150. Krosky, P. M., Baek, M. C., Jahng, W. J. et al. (2003b). The human cytomegalovirus UL44 protein is a substrate for the UL97 pro-tein kinase. J. Virol., 77, 7720-7727.
151. Landini, M. P., Severi, B., Furlini, G., and Badiali De Giorgi, L. (1987). Human cytomegalovirus structural components: Intracellular and intraviral localization of p28 and p65-69 by immunoelec-tron microscopy. Virus Res., 8, 15-23.
152. LaPierre, L. A. and Biegalke, B. J. (2001). Identification of a novel transcriptional repressor encoded by human cytomegalovirus. J. Virol., 75, 6062-6069.
153. Lee, H. R., Kim, D. J., Lee, J. M. et al. (2004). Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcrip-tional regulation and infectivity in cultured fibroblast cells. J. Virol., 78, 6527-6542.
154. Lehner, P. J., Karttunen, J. T., Wilkinson, G. W. G., and Cress-well, P. (1997). The human cytomegalovirus US6 glycopro-tein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc. Natl Acad. Sci. USA, 94, 6904-6909.
155. Lehner, R., Meyer, H., and Mach, M. (1989). Identification and characterization of a human cytomegalovirus gene coding for a membrane protein that is conserved among human her-pesviruses. J. Virol., 63, 3792-3800.
156. Li, L., Nelson, J. A., and Britt, W. J. (1997). Glycoprotein H-related complexes of human cytomegalovirus: Identification of a third protein in the gCIII complex. J. Virol., 71, 3090-3097.
157. Li, J., Yamamoto, T., Ohtsubo, K., Shirakata, M., and Hirai, K. (1999). Major product pp43 of human cytomegalovirus UL 112-113 gene is a transcriptional coactivator with two functionally dis-tinct domains. Virology, 260, 89-97.
158. Lilley, B. N. and Ploegh, H. L. (2004). A membrane protein required for dislocation of misfolded proteins from the ER. Nature, 429, 834-840.
159. Lilley, B. N., Ploegh, H. L., and Tirabassi, R. S. (2001). Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J. Virol., 75, 11218-11221.
160. Lin, K. and Ricciardi, R. P. (1998). The 41-kDa protein of human herpesvirus 6 specifically binds to viral DNA polymerase and greatly increases DNA synthesis. Virology, 250, 210-219.
161. Lindquester, G. J. and Pellett, P. E. (1991). Properties of the human herpesvirus 6 strain Z29 genome: G + C content, length, and presence of variable-length directly repeated terminal sequence elements. Virology, 182, 102-110.
162. Lischka, P., Rosorius, O., Trommer, E. and Stamminger, T. (2001). A novel transferable nuclear export signal mediates CRM1-independent nucleocytoplasmic shuttling of the human cytomegalovirus transactivator protein pUL69. EMBO J., 20, 7271-7283.
163. Lischka, P., Sorg, G., Kann, M., Winkler, M., and Stamminger, T. (2003). A nonconventional nuclear localization signal within the UL84 protein of human cytomegalovirus mediates nuclear import via the importin a./3pathway. J. Virol., 77, 3734-3748.
164. Littler, E., Lawrence, G., Liu, M. Y., Barrell, B. G., and Arrand, J. R. (1990). Identification, cloning, and expression of the major capsid protein gene of human herpesvirus 6. J. Virol., 64, 714-722.
165. Littler, E., Stuart, A. D., and Chee, M. S. (1992). Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganci-clovir. Nature, 358, 160-162.
166. Liu, B. and Stinski, M. F. (1992). Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J. Virol., 66, 4434-4444.
167. Liu, D. X., Gompels, U. A., Nicholas, J., and Lelliott, C. (1993). Iden-tification and expression of the human herpesvirus 6 glyco-protein H and interaction with an accessory 40K glycoprotein. J. Gen. Virol., 74, 1847-1857.
168. Liu, Y. and Biegalke, B. J. (2002). The human cytomegalovirus UL35 gene encodes two proteins with different functions. J. Virol., 76, 2460-2468.
169. Lockridge, K. M., Zhou, S. S., Kravitz, R. H. et al. (2000). Primate cytomegaloviruses encode and express an IL-10-like protein. Virology, 268, 272-280.
170. Lopper, M. and Compton, T. (2002). Disulfide bond configuration of human cytomegalovirus glycoprotein B. J. Virol., 76, 6073-6082.
171. Luttichau, H. R., Clark-Lewis, I., Jensen, P. O., Moser, C., Gerstoft, J., and Schwartz, T. (2003). A highly selective CCR2 chemokine agonist encoded by human herpesvirus 6. J. Biol. Chem., 278, 10928-10933.
172. Mach, M., Kropff, B., Dal Monte, P., and Britt, W. (2000). Com-plex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73). J. Virol., 74, 11881-11892.
173. Machold, R. P., Wiertz, E. J., Jones, T. R., and Ploegh, H. L. (1997). The HCMV gene products US11 and US2 differ in their abil-ity to attack allelic forms of murine major histocompatibility complex (MHC)class I heavy chains. J. Exp. Med., 185, 363-366.
174. Marchini, A., Liu, H., and Zhu, H. (2001). Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol., 75, 1870-1878.
175. Margulies, B. J., Browne, H., and Gibson, W. (1996). Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles. Virology, 225, 111-125.
176. Marks, J. R. and Spector D. H. (1984). Fusion of the termini of the murine cytomegalovirus genome after infection. J. Virol., 52, 24-28.
177. Marks, J. R. and Spector, D. H. (1988). Replication of the murine cytomegalovirus genome: Structure and role of the termini in the generation and cleavage of concatenates. Virology, 162, 98-107.
178. Marschall, M., Freitag, M., Suchy, P. et al. (2003). The protein kinase pUL97 ofhumancytomegalovirusinteracts withandphospho-rylates the DNA polymerase processivity factor pUL44. Virol-ogy, 311, 60-71.
179. Martin, M. E., Nicholas, J., Thomson, B. J., Newman, C., and Honess, R. W. (1991a). Identification of a transactivating function map-ping to the putative immediate-early locus of human her-pesvirus 6. J. Virol., 65, 5381-5390.
180. Martin, M. E., Thomson, B. J., Honess, R. W. et al. (1991b). The genome of human herpesvirus 6: Maps of unit-length and con-catemeric genomes for nine restriction endonucleases. J. Gen. Virol., 72, 157-168.
181. Martin, W. J. (1999). Stealth adaptation of an African green monkey simian cytomegalovirus. Exp. Mol. Pathol., 66, 3-7.
182. Martin, W. J.(2000). Chemokinereceptor-relatedgeneticsequences in an african green monkey simian cytomegalovirus-derived stealth virus. Exp. Mol. Pathol., 69, 10-16.
183. McGeehan, J. E., Depledge, N. W., and McGeoch, D. J. (2001). Evo-lution of the dUTPase gene of mammalian and avian her-pesviruses. Curr. Protein Pept. Sci., 2, 325-333.
184. McGeoch, D. J. and Davison, A. J. (1999). The molecular evolution-ary history of the herpesviruses. In Origin and Evolution of Viruses, pp. 441-465, ed E. Domingo, R. Webster and J. Hol-land. London: Academic Press.
185. McGregor, A. and Schleiss, M. R. (2001). Molecular cloning of the guinea pig cytomegalovirus (GPCMV) genome as an infectious bacterial artificial chromosome (BAC) in Escherichia coli. Mol. Genet. Metab., 72, 15-26.
186. McKeating, J. A., Griffiths, P. D., and Grundy, J. E. (1987). Cytomegalovirus in urine specimens has host [32 microglob-ulin bound to the viral envelope:A mechanism of evading the host immune response? J. Gen. Virol., 68, 785-792.
187. McMahon, T. P. and Anders, D. G. (2002). Interactions between human cytomegalovirus helicase-primase proteins. Virus Res., 86, 39-52.
188. McVoy, M. A., Nixon, D. E., and Adler, S. P. (1997). Circularization and cleavage of guinea pig cytomegalovirus genomes. J. Virol., 71, 4209-4217.
189. Megaw, A. G., Rapaport, D., Avidor, B., Frenkel, N., and Davison, A. J. (1998). The DNA sequence of the RK strain of human her-pesvirus 7. Virology, 244, 119-132.
190. Meijer, H., Dreesen, J. C., and Van Boven, C. P. (1986). Molecu-lar cloning and restriction endonuclease mapping of the rat cytomegalovirus genome. J. Gen. Virol., 67, 1327-1342.
191. Mercer, J. A., Marks, J. R., and Spector, D. H. (1983). Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith strain). Virology, 129, 94-106.
192. Messerle, M., Crnkovic, I., Hammerschmidt, W., Ziegler, H., and Koszinowski, U. H. (1997). Cloning and mutagenesis of a her-pesvirus genome as an infectious bacterial artificial chromo-some. Proc. Natl Acad. Sci. USA, 94, 14759-14763.
193. Meyer, H., Bankier, A. T., and Landini, M. P. (1988). Identifica-tion and procaryotic expression of the gene coding for the highly immunogenic 28-kilodalton structural phosphopro-tein (pp28) of human cytomegalovirus. J. Virol., 62, 2243-2250.
194. Milne, R. S. B, Paterson, D. A., and Booth, J. C. (1998). Human cytomegalovirus glycoprotein H/glycoprotein L complex modulates fusion-from-without. J. Gen. Virol., 79, 855-865.
195. Milne, R. S. B., Mattick, C., Nicholson, L., Devaraj, P., Alcami, A., and Gompels, U. A. (2000). RANTES binding and down-regulation by a novel human herpesvirus-63 chemokine receptor. J. Immunol., 164, 2396-2404.
196. Misaghi, S., Sun, Z. Y., Stern, P., Gaudet, R., Wagner, G., and Ploegh, H. (2004). Structural and functional analysis of human cytomegalovirus US3 protein. J. Virol., 78, 413-423.
197. Mocarski, E. S. (2002). Virus self-improvement through infiamm-ation: No pain, no gain. Proc. Natl Acad. Sci. USA, 99, 3362-3364.
198. Mocarski, E. S., Pereira, L. and Michael, N. (1985). Precise localiza-tion of genes on large animal virus genomes: Use of Agt11 and monoclonal antibodies to map the gene fora cytomegalovirus protein family. Proc. Natl Acad. Sci. USA, 82, 1266-1270.
199. Mocarski, E. S., Pereira, L., and McCormick, L. A. (1988). Human cytomegalovirus ICP22, the product of the HWLF1 reading frame, is an early nuclear protein that is released from cells. J. Gen. Virol., 69, 2613-2621.
200. Mocarski, E. S., Prichard, M. N., Tan, C. S., and Brown J. M. (1997). Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome. Virology, 239, 169-175.
201. Mori, Y., Yagi, H., Shimamoto, T. et al. (1998). Analysis of human herpesvirus 6 U3 gene, which is apositionalhomolog of human cytomegalovirus UL 24 gene. Virology, 249, 129-139.
202. Mori, Y., Dhepakson, P., and Shimamoto, T. (2000). Expression of human herpesvirus 6B rep within infected cells and binding of its gene product to the TATA-binding protein in vitro and in vivo. J. Virol., 74, 6096-6104.
203. Mori, Y., Akkapaiboon, P., Yang, X., and Yamanishi, K. (2003a). The human herpesvirus 6 U100 gene product is the third compo-nent of the gH-gL glycoprotein complex on the viral envelope. J. Virol., 77, 2452-2458.
204. Mori, Y., Yang, X., Akkapaiboon, P., Okuno, T., and Yamanishi, K. (2003b). Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complexassociates with human CD46. J. Virol., 77, 4992-4999.
205. Muranyi, W., Haas, J., Wagner, M., Krohne, G., and Koszinowski, U. H. (2002). Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science, 297, 854-857.
206. Murphy, E., Rigoutsos, I., Shibuya, T., and Shenk, T. E. (2003a). Reevaluation of human cytomegalovirus coding potential. Proc. Natl Acad. Sci. USA, 100, 13585-13590.
207. Murphy, E., Yu, D., Grimwood, J. et al.(2003b). Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl Acad. Sci. USA, 100, 14976-14981.
208. Neipel, F., Ellinger, K., and Fleckenstein, B. (1992). Gene for the major antigenic structural protein (p100) of human her-pesvirus 6. J. Virol., 66, 3918-3924.
209. Neote, K., DiGregorio, D., Mak, J. Y., Horuk, R., and Schall, T. J. (1993). Molecular cloning, functional expression, and signaling char-acteristics of a CC chemokine receptor. Cell, 72, 415-425.
210. Nevels, M., Paulus, C., and Shenk, T. (2004). Human cyto-megalovirus immediate-early 1 protein facilitates viral repli-cation by antagonizing histone deacetylation. Proc. Natl Acad. Sci. USA, 101, 17234-17239.
211. Newcomb, W. W., Homa, F. L., Thomsen, D. R. et al. (1996). Assembly of the herpes simplex virus capsid: Characterization of inter-mediates observed during cell-free capsid formation. J. Mol. Biol., 263, 432-446.
212. Nicholas, J. (1996). Determination and analysis of the complete nucleotide sequence of human herpesvirus 7. J. Virol., 70, 5975-5989.
213. Nikolaou, K., Varinou, L., Inoue, N. and Arsenakis, M. (2003). Identi-fication and characterization of gene products of ORF U90/89 of human herpesvirus 6. Acta Virol., 47, 17-26.
214. Nixon, D. E. and McVoy, M. A. (2002). Terminally repeated sequences on a herpesvirus genome are deleted following circularization but are reconstituted by duplication during cleavage and packaging of concatemeric DNA. J. Virol., 76, 2009-2013.
215. Odeberg, J., Browne, H., Metkar, S. et al. (2003). The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins. J. Virol., 77, 4539-4545.
216. Ogawa-Goto, K., Irie, S., Omori, A. et al. (2002). An endoplas-mic reticulum protein, p180, is highly expressed in human cytomegalovirus-permissive cells and interacts with the tegu-ment protein encoded by UL48. J. Virol., 76, 2350-2362.
217. Oien, N. L., Thomsen, D. R., Wathen, M. W., Newcomb, W. W., Brown, J. C., and Homa, F. L. (1997). Assembly of herpes simplex virus capsids using the human cytomegalovirus scaffold protein: Critical role of the C terminus. J. Virol., 71, 1281-1291.
218. Okamoto, H., Takahashi, M., Nishizawa, T. et al. (2002). Genomic characterization of TT viruses (TTVs) in pigs, cats and dogs and their relatedness with species-specific TTVs in primates and tupaias. J. Gen. Virol., 83, 1291-1297.
219. Papanikolaou, E., Kouvatsis, V., Dimitriadis, G., Inoue, N., and Arse-nakis, M. (2002). Identification and characterization of the gene products of open reading frame U86/87 of human her-pesvirus 6. Virus. Res., 89, 89-101.
220. Patrone, M., Percivalle, E., Secchi, M. et al.(2003). The human cytomegalovirus UL45 gene product is a late, virion-associated protein and influences virus growth at low multiplicities of infection. J. Gen. Virol., 84, 3359-3370.
221. Patrone, M., Secchi, M., Fiorina, L., Ierardi, M., Milanesi, G., and Gallina, A. (2005). Human cytomegalovirus UL130 protein promotes endothelial cell infection through a producer cell modification of the virion. J. Virol., 79, 8361-8373.
222. Patterson, C. E. and Shenk, T. (1999). Human cytomegalovirusUL36 protein is dispensable for viral replication in cultured cells. J. Virol., 73, 7126-7131.
223. Penfold, M. E. and Mocarski, E. S. (1997). Formation of cytome-galovirus DNA replication compartments defined by localiza-tion of viral proteins and DNA synthesis. Virology, 239, 46-61.
224. Penfold, M. E., Dairaghi, D. J., Duke, G. M. et al. (1999). Cytomegalovirus encodes a potent a.chemokine. Proc. Natl Acad. Sci. USA, 96, 9839-9844.
225. Penfold, M. E., Schmidt, T. L., Dairaghi, D. J., Barry, P. A., and Schall, T. J. (2003). Characterization of the rhesus cytomegalovirus US28 locus. J. Virol., 77, 10404-10413.
226. Peters, M. A., Jackson, D. C., Crabb, B. S., and Browning, G. F. (2002). Chicken anemia virus VP2 is a novel dual specificity protein phosphatase. J. Biol. Chem., 277, 39566-39573.
227. Pfeiffer, B., Thomson, B., and Chandran, B. (1995). Identification and characterization of a cDNA derived from multiple splic-ing that encodes envelope glycoprotein gp105 of human her-pesvirus 6. J. Virol., 69, 3490-3500.
228. Pignatelli, S., Dal Monte, P., Rossini, G. and Landini, M. P. (2004). Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev. Med. Virol., 14, 383-410.
229. Prichard, M. N., Duke, G. M., and Mocarski, E. S. (1996). Human cytomegalovirus uracil DNA glycosylase is required for the nor-mal temporal regulation of both DNA synthesis and viral repli-cation. J. Virol., 70, 3018-3025.
230. Prichard, M. N., Jairath, S., Penfold, M. E., St. Jeor, S., Bohlman, M. C., and Pari, G. S. (1998). Identification of persistent RNA-DNA hybrid structures within the origin of replication of human cytomegalovirus. J. Virol., 72, 6997-7004.
231. Prichard, M. N., Penfold, M. E., Duke, G. M., Spaete, R. R., and Kem-ble, G. W. (2001). A review of genetic differences between lim-ited and extensively passaged human cytomegalovirus strains. Rev. Med. Virol., 11, 191-200.
232. Prince, V. E. and Pickett, F. B. (2002). Splitting pairs: The diverging fates of duplicated genes. Nat. Rev. Genet., 3, 827-837.
233. Qiu, X., Culp, J. S., DiLella, A. G. et al. (1996). Unique fold and active site in cytomegalovirus protease. Nature, 383, 275-279.
234. Rasmussen, L., Geissler, A., and Winters, M. (2003). Inter-and intra-genic variations complicate the molecular epidemiology of human cytomegalovirus. J. Infect. Dis., 187, 809-819.
235. Rawlinson, W. D. and Barrell, B. G. (1993). Spliced transcripts of human cytomegalovirus. J. Virol., 67, 5502-5513.
236. Rawlinson, W. D., Farrell, H. E., and Barrell, B. G. (1996). Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol., 70, 8833-8849.
237. Reid, G. G., Ellsmore, V., and Stow, N. D. (2003). An analysis of the requirements for human cytomegalovirus ori Lyt-dependent DNA synthesis in the presence of the herpes simplex virus type 1 replication fork proteins. Virology, 308, 303-316.
238. Richman, L. K., Montali, R. J., Garber, R. L. et al. (1999). Novel endotheliotropic herpesviruses fatal for Asian and African ele-phants. Science, 283, 1171-1176.
239. Robson, L. and Gibson, W. (1989). Primate cytomegalovirus assembly protein: Genome location and nucleotide sequence. J. Virol., 63, 669-676.
240. Roby, C. and Gibson, W. (1986). Characterization of phospho-proteins and protein kinase activity of virions, noninfec-tious enveloped particles, and dense bodies of human cytomegalovirus. J. Virol., 59, 714-727.
241. Romanowski, M. J. and Shenk, T. (1997). Characterization of the human cytomegalovirus irs1 and trs1 genes: A second immediate-early transcription unit within irs1 whose product antagonizes transcriptional activation. J. Virol., 71, 1485-1496.
242. Romanowski, M. J., Garrido-Guerrero, E., and Shenk, T. (1997). pIRS1 and pTRS1 are present in human cytomegalovirus viri-ons. J. Virol., 71, 5703-5705.
243. Rotola, A., Ravaioli, T., Gonelli, A., Dewhurst, S., Cassai, E., and Di Luca, D. (1998). U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc. Natl Acad. Sci. USA, 95, 13911-13916.
244. Ruger, B., Klages, S., Walla, B. et al. (1987). Primary structure and transcription of the genes coding for the two virion phospho-proteins pp65 and pp71 of human cytomegalovirus. J. Virol., 61, 446-453.
245. Rupasinghe, V., Iwatsuki-Horimoto, K., Sugii, S., and Horimoto, T. (2001). Identification of the porcine cytomegalovirus major capsid protein gene. J. Vet. Med. Sci., 63, 609-618.
246. Sahagun-Ruiz, A., Sierra-Honigmann, A. M., Krause, P., and Mur-phy, P. M. (2004). Simian cytomegalovirus encodes five rapidly evolving chemokine receptor homologues. Virus Genes, 28, 71-83.
247. Sanchez, V., Sztul, E., and Britt, W. J. (2000). Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-Golgi-intermediate com-partment. J. Virol., 74, 3842-3851.
248. Santoro, F., Greenstone, H. L., Insinga, A. et al. (2003). Interaction of glycoprotein H of human herpesvirus 6 with the cellular receptor CD46. J. Biol. Chem., 278, 25964-25969.
249. Sarisky, R. T. and Hayward, G. S. (1996). Evidence that the UL84 gene product of human cytomegalovirus is essential for pro-moting ori Lyt-dependent DNA replication and formation of replication compartments in cotransfection assays. J. Virol., 70, 7398-7413.
250. Scalzo, A. A., Dallas, P. B., Forbes, C. A. et al. (2004). The murine cytomegalovirus M73.5 gene, a member of a 3’ co-terminal alternatively spliced gene family, encodes the gp24 virion gly-coprotein. Virology, 329, 234-250.
251. Scheffczik, H., Savva, C. G., Holzenburg, A., Kolesnikova, L., and Bogner, E. (2002). The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure. Nucl. Acids Res., 30, 1695-1703.
252. Schierling, K., Stamminger, T., Mertens, T., and Winkler, M. (2004). Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer. J. Virol., 78, 9512-9523.
253. Sedarati, F. and Rosenthal, L. J. (1988). Isolation and partial char-acterization of nucleocapsid forms from cells infected with human cytomegalovirus strains AD169 and Towne. Intervirol-ogy, 29, 86-100.
254. Sheaffer, A. K., Weinheimer, S. P., and Tenney, D. J. (1997). The human cytomegalovirus UL98 gene encodes the con-served herpesvirus alkaline nuclease. J. Gen. Virol., 78, 2953-2961.
255. Shieh, H. S., Kurumbail, R. G., Stevens, A. M. et al. (1996). Three-dimensional structure of human cytomegalovirus protease. Nature, 383, 279-282.
256. Silva, M. C., Yu, Q. C., Enquist, L., and Shenk, T. (2003). Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids. J. Virol., 77, 10594-10605.
257. Simmen, K. A., Singh, J., Luukkonen, B. G. et al. (2001). Global mod-ulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc. Natl Acad. Sci. USA, 98, 7140-7145.
258. Skaletskaya, A., Bartle, L. M., Chittenden, T., McCormick, A. L., Mocarski, E. S., and Goldmacher, V. S. (2001). A cytomegalovirus-encoded inhibitor of apoptosis that sup-presses caspase-8 activation. Proc. Natl Acad. Sci. USA, 98, 7829-7834.
259. Smith, J. A. and Pari, G. S. (1995a). Human cytomegalovirus UL102 gene. J. Virol., 69, 1734-1740.
260. Smith, J. A. and Pari, G. S. (1995b). Expression of human cytome-galovirus UL36 and UL37 genes is required for viral DNA replication. J. Virol., 69, 1925-1931.
261. Smith, J. A., Jairath, S., Crute, J. J., and Pari, G. S. (1996). Char-acterization of the human cytomegalovirus UL105 gene and identification of the putative helicase protein. Virology, 220, 251-255.
262. Spaderna, S., Blessing, H., Bogner, E., Britt, W., and Mach, M. (2002). Identification of glycoprotein gpTRL10 as a structural component of human cytomegalovirus. J. Virol., 76, 1450-1460.
263. Spaete, R. R. and Mocarski, E. S. (1985). The asequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes. J. Virol., 54, 817-824.
264. Spaete, R. R., Perot, K., Scott, P. I., Nelson, J. A., Stinski, M. F., and Pachl, C. (1993). Coexpression of truncated human cytomegalovirus gH with the UL115 gene product or the trun-cated human fibroblast growth factor receptor results in trans-port of gH to the cell surface. Virology, 193, 853-861.
265. Spear, G. T., Lurain, N. S., Parker, C. J., Ghassemi, M., Payne, G. H., and Saifuddin, M. (1995). Host cell-derived comple-ment control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). J. Immunol., 155, 4376-4381.
266. Speir, E., Yu, Z. X., Ferrans, V. J., Huang, E. S., and Epstein, S. E. (1998). Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ. Res., 83, 210-216.
267. Stamminger, T., Gstaiger, M., Weinzierl, K., Lorz, K., Winkler, M., and Schaffner, W. (2002). Open reading frame UL26 of human cytomegalovirus encodes a novel tegument protein that con-tains a strong transcriptional activation domain. J. Virol., 76, 4836-4847.
268. Stannard, L. M. (1989). 32 microglobulin binds to the tegument of cytomegalovirus: An immunogold study. J. Gen. Virol., 70, 2179-2184.
269. Stanton, R., Wilkinson, G. W. G., and Fox, J. D. (2003). Analysis of human herpesvirus-6 IE1 sequence variation in clinical sam-ples. J. Med. Virol., 71, 578-584.
270. Stasiak, P. C. and Mocarski, E. S. (1992). Transactivation of the cytomegalovirus ICP36 gene promoter requires the a.gene product TRS1 in addition to IE1 and IE2. J. Virol., 66, 1050-1058.
271. Stefan, A., Secchiero, P., Baechi, T., Kempf, W., and Campadelli-Fiume, G. (1997). The 85-kilodalton phosphoprotein (pp85) of human herpesvirus 7 is encoded by open reading frame U14 and localizes to a tegument substructure in virion particles. J. Virol., 71, 5758-5763.
272. Streblow, D. N., Soderberg-Naucler, C., Vieira, J. et al. (1999). The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell, 99, 511-520.
273. Sullivan, V., Talarico, C. L., Stanat, S. C., Davis, M., Coen, D. M., and Biron, K. K. (1992). A protein kinase homologue controls phos-phorylation of ganciclovir in human cytomegalovirus-infected cells. Nature, 358, 162-164.
274. Sun, Y. and Conner, J. (1999). The U28 ORF of human herpesvirus-7 does not encode a functional ribonucleotide reductase R1 subunit. J. Gen. Virol., 80, 2713-2718.
275. Takemoto, M., Shimamoto, T., Isegawa, Y., and Yamanishi, K. (2001). The R3 region, one of three major repetitive regions of human herpesvirus 6, is a strong enhancer of immediate-early gene U95. J. Virol., 75, 10149-10160.
276. Talarico, C. L., Burnette, T. C., Miller, W. H. et al.(1999). Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein. Antimicrob. Agents Chemother., 43, 1941-1946.
277. Tamashiro, J. C. and Spector, D. H. (1986). Terminal structure and heterogeneity in human cytomegalovirus strain AD169. J. Virol., 59, 591-604.
278. Teo, I. A., Griffin, B. E., and Jones, M. D. (1991). Characterization of the DNA polymerase gene of human herpesvirus 6. J. Virol., 65, 4670-4680.
279. Terhune, S. S., Schroer, J., and Shenk, T. (2004). RNAs are pack-aged into human cytomegalovirus virions in proportion to their intracellular concentration. J. Virol., 78, 10390-10398.
280. Thomson, B. J., Efstathiou, S., and Honess, R. W. (1991). Acquisi-tion of the human adeno-associated virus type-2 repgene by human herpesvirus type-6. Nature, 351, 78-80.
281. Tigue, N. J., Matharu, P. J., Roberts, N. A., Mills, J. S., Kay, J., and Jupp, R. (1996). Cloning, expression and characterization of the proteinase from human herpesvirus 6. J. Virol., 70, 4136-4141.
282. Tirabassi, R. S. and Ploegh, H. L. (2002). The human cytomegalovirus US8 glycoprotein binds to major histocom-patibility complex class I products. J. Virol., 76, 6832-6835.
283. Tomasec, P., Braud, V. M., Rickards, C. et al. (2000). Surface expres-sion of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science, 287, 1031.
284. Tomasec, P., Wang, E. C., Davison, A. J. et al. (2005). Downregula-tion of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat. Immunol., 6, 181-188.
285. Tomazin, R., Boname, J., Hegde, N. R. et al.(1999). Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat. Med., 5, 1039-1043.
286. Tong, L., Qian, C., Massariol, M. J., Bonneau, P. R., Cordingley, M. G., and Lagace, L. (1996). A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease. Nature, 383, 272-275.
287. Trus, B. L., Homa, F. L., Booy, F. P. et al.(1995). Herpes simplex virus capsids assembled in insect cells infected with recombinant baculoviruses: Structural authenticity and localization of VP26. J. Virol., 69, 7362-7366.
288. Trus, B. L., Gibson, W., Cheng, N., and Steven, A. C. (1999). Cap-sid structure of simian cytomegalovirus from cryoelectron microscopy: Evidence for tegument attachment sites. J. Virol., 73, 2181-2192.
289. Trus, B. L., Heymann, J. B., Nealon, K. et al. (2001). Capsid struc-ture of Kaposi‘s sarcoma-associated herpesvirus, a gammaher-pesvirus, compared to those of an alphaherpesvirus, herpes simplex virus type 1, and a betaherpesvirus, cytomegalovirus. J. Virol., 75, 2879-2890.
290. van Zeijl, M., Fairhurst, J., Baum, E. Z., Sun, L., and Jones, T. R.(1997). The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology, 231, 72-80.
291. Varnum, S. M., Streblow, D. N., Monroe, M. E. et al.(2004). Identifica-tion of proteins in human cytomegalovirus (HCMV) particles: The HCMV proteome. J. Virol., 78, 10960-10966.
292. Vey, M., Schafer, W., Reis, B. et al.(1995). Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin. Virology, 206, 746-749.
293. Vink, C., Beuken, E., and Bruggeman, C. A. (1996). Structure of the rat cytomegalovirus genome termini. J. Virol., 70, 5221-5229.
294. Vink, C., Beuken, E., and Bruggeman, C. A. (2000). Complete DNA sequence of the rat cytomegalovirus genome. J. Virol., 74, 7656-7665.
295. Wang, D. and Shenk, T. (2005). Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc. Natl Acad. Sci. USA, 102, 18153-18158.
296. Wang, S. K., Duh, C. Y., and Chang, T. T. (2000). Cloning and iden-tification of regulatory gene UL76 of human cytomegalovirus. J. Gen. Virol., 81, 2407-2416.
297. Wang, S. K., Duh, C. Y., and Wu, C. W. (2004). Human cytome-galovirus UL76 encodes a novel virion-associated protein that is able to inhibit viral replication. J. Virol., 78, 9750-9762.
298. Weiland, K. L, Oien, N. L., Homa, F., and Wathen, M. W.(1994). Func-tional analysis of human cytomegalovirus polymerase acces-sory protein. Virus. Res., 34, 191-206.
299. Welch, A. R., Woods, A. S., McNally, L. M., Cotter, R. J., and Gibson, W. (1991). A herpesvirus maturational proteinase, assemblin: Identification of its gene, putative active site domain, and cleavage site. Proc. Natl Acad. Sci. USA, 88, 10792-10796.
300. Welch, A. R., McNally, L. M., Hall, M. R., and Gibson, W. (1993). Her-pesvirus proteinase: Site-directed mutagenesis used to study maturational, release, and inactivation cleavage sites of pre-cursor and to identifya possible catalytic site serine and histi-dine. J. Virol., 67, 7360-7372.
301. Weststrate, M. W., Geelen, J. L., and van der Noordaa, J. (1980). Human cytomegalovirus DNA: Physical maps for restriction endonucleases BglII, Hin dIII and XbaI. J. Gen. Virol., 49, 1-21.
302. Widen, F., Goltz, M., Wittenbrink, N., Ehlers, B., Banks, M., and Belak, S. (2001). Identification and sequence analysis of the glycoprotein B gene of porcine cytomegalovirus. Virus Genes, 23, 339-346.
303. Wiertz, E. J., Jones, T. R., Sun, L., Bogyo, M., Geuze, H. J., and Ploegh, H. L. (1996a). The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell, 84, 769-779.
304. Wiertz, E. J., Tortorella, D., Bogyo, M. et al. (1996b). Sec61-mediated transfer of a membrane protein from the endoplasmic reticu-lum to the proteasome for destruction. Nature, 384, 432-438.
305. Wills, M. R., Ashiru, O., Reeves, M. B. et al. (2005). Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J. Immunol., 175, 7457-7465.
306. Wing, B. A., Lee, G. C., and Huang, E. S. (1996). The human cytomegalovirus UL94 open reading frame encodes a con-served herpesvirus capsid/tegument-associated virion pro-tein that is expressed with true late kinetics. J. Virol., 70, 3339-3345.
307. Winkler, M. and Stamminger, T. (1996). A specific subform of the human cytomegalovirus transactivator protein pUL69 is con-tainedwithin the tegumentof virus particles. J. Virol., 70, 8984-8987.
308. Winkler, M., Rice, S. A., and Stamminger, T. (1994). UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J. Virol., 68, 3943-3954.
309. Wolf, D. G., Courcelle, C. T., Prichard, M. N. and Mocarski, E. S. (2001). Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsi-dation. Proc. Natl Acad. Sci. USA, 98, 1895-1900.
310. Wood, L. J., Baxter, M. K., Plafker, S. M., and Gibson, W. (1997). Human cytomegalovirus capsid assembly protein precursor (pUL80.5) interacts with itself and with the major capsid pro-tein (pUL86) through two different domains. J. Virol., 71, 179-190.
311. Wright, J. F., Kurosky, A., Pryzdial, E. L., and Wasi, S. (1995). Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts. J. Virol., 69, 4784-4791.
312. Xu, Y., Ahn, J. H., Cheng, M. et al. (2001). Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression. J. Virol., 75, 10683-10695.
313. Xu, Y., Cei, S. A., Huete, A. R., and Pari, G. S. (2004). Human cytomegalovirus UL84 insertion mutant defective for viral DNA synthesis and growth. J. Virol., 78, 10360-10369.
314. Yu, D., Smith, G. A., Enquist, L. W., and Shenk, T. (2002). Construc-tion of a self-excisable bacterial artificial chromosome con-taining the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J. Virol., 76, 2316-2328.
315. Yu, D., Silva, M. C., and Shenk, T. (2003). Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc. Natl Acad. Sci. USA, 100, 12396-12401.
316. Yu, X., Shah, S., Atanasov, I. et al. (2005). Three-dimensional localization of the smallest capsid protein in the human cytomegalovirus capsid. J. Virol., 79, 1327-1332.
317. Zhao, Y. and Biegalke, B. J. (2003). Functional analysis of the human cytomegalovirus immune evasion protein, pUS3(22kDa). Virology, 315, 353-361.
318. Zhou, Z. H., He, J., Jakana, J., Tatman, J. D., Rixon, F. J., and Chiu, W. (1995). Assembly of VP26 in herpes simplex virus-1 inferred from structures of wild-type and recombinant capsids. Nat. Struct. Biol., 2, 1026-1030.
319. Zhou, Z. H., Chen, D. H., Jakana, J., Rixon, F. J., and Chiu, W. (1999). Visualization of tegument-capsid interactions and DNA in intact herpes simplex virus type 1 virions. J. Virol., 73, 3210-3218.
320. Zhu, H., Cong, J. P., Mamtora, G., Gingeras, T., and Shenk, T. (1998). Cellular gene expression altered by human cytomegalovirus: Global monitoring with oligonucleotide arrays. Proc. NatlAcad. Sci. USA, 95, 14470-14475.
321. Zhu, H., Cong, J. P., Yu, D., Bresnahan, W. A., and Shenk, T. E. (2002). Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc. Natl Acad. Sci. USA, 99, 3932-3937.
322. Zou, P., Isegawa, Y., Nakano, K., Haque, M., Horiguchi, Y., and Yamanishi, K. (1999). Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J. Virol., 73, 5926-5933.